New pill aims to stop chemo sickness for breast cancer patients
NCT ID NCT03386617
First seen Mar 07, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study tests a fixed-dose combination pill called NEPA (netupitant and palonosetron) to prevent nausea and vomiting in 55 women with early breast cancer receiving chemotherapy with adriamycin and cyclophosphamide in Hong Kong. The goal is to see how well the drug works during the first few days after treatment. Participants take the pill before chemotherapy and record their symptoms in a diary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.